{2 (1 ML certolizumab pegol 200 MG/ML Prefilled Syringe [Cimzia]) } Pack [Cimzia (2 count)... — RxCUI 2724370
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Certolizumab Injection: what it is, how it’s used, side effects, and interactions.
- Cimzia is used to treat several inflammatory conditions driven by an overactive immune protein called TNFα. In adults, it can be used for Crohn's disease, rheumatoid arthritis, pso...
- Cimzia comes as a prefilled syringe that you inject under the skin — usually into your thigh or abdomen — after getting trained by your healthcare provider. Take it out of the frid...
- How do I give myself this injection, and does it hurt?
- The biggest concern with Cimzia is serious infections — including tuberculosis, fungal infections, and bacterial infections. Call your doctor right away if you develop a fever, chi...
🕸️ Concept Web — How {2 (1 ML certolizumab pegol 200 MG/ML Prefilled... Connects
RxCUI 2724370 Brand name pack · BPCK
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Certolizumab pegol
709271IN
-
Certolizumab pegol
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Cimzia
795082BN
-
Cimzia
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Certolizumab pegol Prefilled Syringe
849596SCDF -
Certolizumab pegol Injectable Product
1161226SCDG -
Certolizumab pegol Prefilled Syringe [Cimzia]
849598SBDF -
Cimzia Injectable Product
1170885SBDG -
Pack
746839DF -
Injectable Product
1151126DFG
-
Certolizumab pegol Prefilled Syringe
-
Clinical & branded drugs 4
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
1 ML certolizumab pegol 200 MG/ML Prefilled Syringe
849597SCD -
Certolizumab pegol 200 MG/ML
795079SCDC -
1 ML certolizumab pegol 200 MG/ML Prefilled Syringe [Cimzia]
849599SBD -
Certolizumab pegol 200 MG/ML [Cimzia]
795083SBDC
-
1 ML certolizumab pegol 200 MG/ML Prefilled Syringe
-
Packs 1
Fixed collections of drugs packaged and sold together, like dose packs.
🔀 Generic ⇄ Brand Crosswalk
Generic (Clinical) Concepts
-
1 ML certolizumab pegol 200 MG/ML Prefilled Syringe
SCD · 849597 -
{2 (1 ML certolizumab pegol 200 MG/ML Prefilled Syringe) } Pack
GPCK · 2724369 -
Certolizumab pegol 200 MG/ML
SCDC · 795079 -
Certolizumab pegol Prefilled Syringe
SCDF · 849596 -
Certolizumab pegol Injectable Product
SCDG · 1161226
Brand-Name Concepts
-
1 ML certolizumab pegol 200 MG/ML Prefilled Syringe [Cimzia]
SBD · 849599 -
Certolizumab pegol 200 MG/ML [Cimzia]
SBDC · 795083 -
Certolizumab pegol Prefilled Syringe [Cimzia]
SBDF · 849598 -
Cimzia Injectable Product
SBDG · 1170885 -
Cimzia
BN · 795082
📦 FDA Products & Package NDCs
3 products · 6 package NDCs
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 50474-0700-61 | 2 KIT in 1 CARTON (50474-700-61) / 1 KIT in 1 KIT * 1 mL i... | Cimzia | UCB, Inc. | 2008-04-20 |
| 50474-0700-62 | 2 KIT in 1 CARTON (50474-700-62) / 1 KIT in 1 KIT * 1 mL i... | Cimzia | UCB, Inc. | 2008-04-20 |
| 50474-0710-79 | 2 SYRINGE, GLASS in 1 CARTON (50474-710-79) / 1 mL in 1 SYR... | Cimzia | UCB, Inc. | 2009-05-14 |
| 50474-0710-80 | 2 SYRINGE, GLASS in 1 CARTON (50474-710-80) / 1 mL in 1 SYR... | Cimzia | UCB, Inc. | 2009-05-14 |
| 50474-0710-81 | 3 CARTON in 1 BOX (50474-710-81) / 2 SYRINGE, GLASS in 1 CA... | Cimzia | UCB, Inc. | 2009-05-14 |
| 50474-0750-10 | 1 SYRINGE, GLASS in 1 CARTON (50474-750-10) / 1 mL in 1 SYR... | Cimzia | UCB, Inc. | 2025-03-01 |
🧾 Billing Codes (HCPCS)
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J0717 | Certolizumab pegol inj 1mg | 4 | CMS |
🗃️ Sources & Limits
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.